ArriVent BioPharma, Inc. Common Stock AVBP

$15.09 -46.98% at last close

Analyst Consensus

Consensus Rating
Buy (8 Buy · 0 Hold · 0 Sell)
Average Price Target
$44.86
Implied Upside
+197.3%
Price Target Range
$40.00 – $50.00
Analysts (12 mo)
8

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-08-17
HC Wainwright & Co.Robert Burns
Maintains Buy $44 → $47
2026-08-13
CitigroupYigal Nochomovitz
Maintains Buy $43 → $40
2026-08-13
GuggenheimMichael Schmitz
Reiterates Buy $45
2026-08-13
BTIGJeet Mukherjee
Reiterates Buy $42
2026-05-29
Truist SecuritiesSupawat Thongthip
Maintains Buy $43 → $45
2026-05-13
CitigroupYigal Nochomovitz
Maintains Buy $45 → $43
2026-04-24
CitigroupYigal Nochomovitz
Maintains Buy $33 → $45
2026-03-23
B. Riley SecuritiesKalpit Patel
Maintains Buy $37 → $45
2026-03-12
BTIGJeet Mukherjee
Assumes Buy $42
2026-03-06
OppenheimerJeff Jones
Reiterates Outperform $44 → $50
2026-03-06
CitigroupYigal Nochomovitz
Maintains Buy $31 → $33
2026-03-06
HC Wainwright & Co.Robert Burns
Maintains Buy $42 → $44
2025-12-23
Cantor FitzgeraldLi Watsek
Initiates coverage on Overweight —
2025-12-10
BTIGJustin Zelin
Initiates coverage on Buy $45
2025-11-25
Truist SecuritiesAsthika Goonewardene
Initiates coverage on Buy $43
2025-11-11
CitigroupYigal Nochomovitz
Maintains Buy $33 → $31
2025-08-12
HC Wainwright & Co.Robert Burns
Maintains Buy $40 → $42
2025-08-12
CitigroupYigal Nochomovitz
Maintains Buy $40 → $33
2025-07-22
HC Wainwright & Co.Robert Burns
Reiterates Buy $40
2025-07-10
Goldman SachsCorinne Johnson
Reinstates Buy $33
2025-06-25
Clear StreetKaveri Pohlman
Initiates coverage on Buy $32
2025-06-24
OppenheimerJeff Jones
Maintains Outperform $39 → $44
2025-06-24
GuggenheimMichael Schmidt
Reiterates Buy $45
2025-05-20
Jones TradingSoumit Roy
Initiates coverage on Buy $40
2025-05-14
HC Wainwright & Co.Robert Burns
Maintains Buy $39 → $40
2025-03-20
B. Riley SecuritiesKalpit Patel
Initiates coverage on Buy $37
2025-03-10
GuggenheimMichael Schmidt
Initiates coverage on Buy $45
2025-03-07
HC Wainwright & Co.Robert Burns
Reiterates Buy $39
2025-01-22
HC Wainwright & Co.Robert Burns
Maintains Buy $36 → $39
2024-11-15
HC Wainwright & Co.Robert Burns
Reiterates Buy $36

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$15.09
Market Cap
$1.40 billion
52-Week Range
$11.36 – $35.83
Average Volume
1.24 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.